drugset / Trial / NCT01601314

Perioperative Magnesium Sulphate as a Cerebral Protector in Neurosurgical Patients

NCT01601314

Phase 3 Completed 55 enrolled Sara Varea
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to determine the relationship between magnesium sulphate administration and levels of S100B protein in serum of patients undergoing supratentorial brain parenchymal resection.

Timeline

Start
2012-10
Primary completion
2017-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 20 g Intravenous

Indications